Oppenheimer analyst Francois Brisebois reiterated an Outperform rating and $22.00 price target on Avadel Pharmaceuticals (NASDAQ: AVDL)The analyst comments "Avadel's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE